PDLI - PDL BioPharma, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue320,060244,301590,448
Cost of Revenue30,5374,065-
Gross Profit289,523240,236590,448
Operating Expenses
Research Development7,3813,8203,820
Selling General and Administrative63,67387,68740,069
Non Recurring-7,2997,299
Total Operating Expenses-110,834-
Operating Income or Loss193,780129,402550,379
Income from Continuing Operations
Total Other Income/Expenses Net10,968-1,7656,818
Earnings Before Interest and Taxes204,748127,637557,197
Interest Expense20,22118,26727,059
Income Before Tax184,527109,370530,138
Income Tax Expense73,82645,711197,343
Minority Interest-4,2804,280
Net Income From Continuing Ops110,74861,253339,245
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income110,74863,606332,795
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares110,74863,606332,795